MultiHub Forum

I'm an infectious disease pharmacist at a mid-sized hospital, and I'm deeply concerned about our rising rates of carbapenem-resistant Enterobacteriaceae in the ICU. Our current antimicrobial stewardship program feels reactive rather than preventive. For other stewardship team members, what proactive interventions have you implemented that actually moved the needle on resistance rates? I'm particularly interested in practical strategies for improving diagnostic stewardship, like optimizing the use of rapid molecular tests to de-escalate therapy faster, and how to effectively engage surgeons and intensivists who are often hesitant to change empiric protocols. Are there any data-driven benchmarks for appropriate antibiotic use in specific patient populations?